Katerina Chatzi Ph.D co-founded Promakhos Therapeutics in 2021 and secured seed funding for the company. Previously, she was a postdoc in the Department of Molecular and Cellular Biology at Harvard . Katerina has extensive experience and publications on how bacterial molecules (secretory molecules and metabolites) act as modulators of innate immunity. Her experience led to the scientific foundation of Promakhos Therapeutics.